logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Over-hyped promises fall flat as budget and premium take a downturn

14 December 2010

The government have announced that, contrary to previous statements, the education budget will not rise in real terms over the next 4 years due to changes to the forecast of inflation. They have also announced that the pupil premium will be £430 per pupil whose family earns less than £16,000. Not only is this significantly less than expected, it has been confirmed that it is money which has been recycled from other areas of school funding rather than a fresh injection of cash.

Russell Hobby from the NAHT has described the pupil premium a ‘damp squib’ since the amount is so low that targeted education provision and other such initiatives will not be feasible. Even if the pupil premium does incentivise schools to admit disadvantaged pupils, they are under no obligation to spend the additional money on their poorer pupils. This watered-down pupil premium may end up making no real impact on the educational prospects of the most disadvantaged pupils.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up